AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis. - Wikidata - wikimedia - TriplyDB

AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis.

AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis.

http://www.wikidata.org/entity/Q34244912

about

Armand-Frappier Outstanding Student Award--The emerging role of 25-hydroxycholesterol in innate immunity Feeding uninvited guests: mTOR and AMPK set the table for intracellular pathogens Lipids at the interface of virus-host interactions Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection Effects of Interferons and Viruses on Metabolism Changes in the Proteome of Langat-Infected Ixodes scapularis ISE6 Cells: Metabolic Pathways Associated with Flavivirus Infection Murine cutaneous responses to the rocky mountain spotted fever vector, Dermacentor andersoni, feeding.MicroRNA regulation of bovine monocyte inflammatory and metabolic networks in an in vivo infection model.Listeria monocytogenes infection causes metabolic shifts in Drosophila melanogaster.Genome-wide RNAi screen identifies broadly-acting host factors that inhibit arbovirus infection.Japanese encephalitis virus nonstructural protein NS5 interacts with mitochondrial trifunctional protein and impairs fatty acid β-oxidation.DENV up-regulates the HMG-CoA reductase activity through the impairment of AMPK phosphorylation: A potential antiviral target.AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus.Porcine Circovirus Type 2 Activates CaMMKβ to Initiate Autophagy in PK-15 Cells by Increasing Cytosolic Calcium.Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.A conserved virus-induced cytoplasmic TRAMP-like complex recruits the exosome to target viral RNA for degradation.Host AMPK Is a Modulator of Plasmodium Liver Infection Antiviral autophagy restrictsRift Valley fever virus infection and is conserved from flies to mammals.Hantavirus immunology of rodent reservoirs: current status and future directions.Germinal center kinases in immune regulation.AMP-activated Protein Kinase As a Target For Pathogens: Friends Or Foes?Nutrient sensing and metabolic stress pathways in innate immunity.Lipids in innate antiviral defense.Targeting of the hydrophobic metabolome by pathogens.Interactions of porcine circovirus 2 with its hosts.Fatty acid elongase 7 catalyzes lipidome remodeling essential for human cytomegalovirus replication.The anti-obesity drug orlistat reveals anti-viral activity.AMPK in Pathogens.Dengue Virus Activates the AMP Kinase-mTOR Axis To Stimulate a Proviral Lipophagy.Viral Immunofluorescence with Rift Valley Fever Virus Infected MEFs in a 96 Well Plate.AMP-activated Kinase (AMPK) Promotes Innate Immunity and Antiviral Defense through Modulation of Stimulator of Interferon Genes (STING) Signaling.Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function.Suppression of Zika virus infection and replication in endothelial cells and astrocytes by PKA inhibitor PKI 14-22.Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.Metformin: a cheap and well-tolerated drug that provides benefits for viral infections.Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase.MicroRNA miR-214 Inhibits Snakehead Vesiculovirus Replication by Promoting IFN-α Expression via Targeting Host Adenosine 5'-Monophosphate-Activated Protein Kinase.MicroRNA miR-214 Inhibits Snakehead Vesiculovirus Replication by Promoting IFN-α Expression via Targeting Host Adenosine 5′-Monophosphate-Activated Protein Kinase.Interferons: Reprogramming the Metabolic Network against Viral Infection.Energy Demands of Early Life Drive a Disease Tolerant Phenotype and Dictate Outcome in Neonatal Bacterial Sepsis

P2860

Q26800190-C32006E0-9375-4AFA-B49A-737E42920D9E Q26859304-040E9677-AA91-4AB4-80B0-D7AFEB53B870 Q26860983-B2AFDDE6-15DC-4CB2-844A-8D0B0DA616AC Q28083186-80877C73-B577-4C15-93CF-AB66952D6514 Q28353943-4E5C1D7F-FCAD-49AE-B22A-9D718B9F2AE2 Q28550057-C77F392F-2AA9-4B95-B951-F6B006DB0246 Q33605990-1673F325-3154-4F4F-802B-D2666251F8B1 Q33785010-66AEE41F-9C46-422C-BA2C-31970FD0CE89 Q34524970-5D906108-33F4-4E21-A0B1-4F40A6A8E97F Q35097100-CB5BFBBF-31F7-4EF4-A2F9-1E02BCCF61EB Q35224602-BF5F625C-CCDD-4987-905B-6126D52FBF29 Q36338285-7560DD32-E77D-4C78-A0D4-EE9656A51DD5 Q36559650-47E44D66-3F7E-4C63-8B97-E4CB2463E093 Q36947027-5CF05BDB-1FDC-4B83-80A2-3FFF7972D808 Q37073302-91D476E7-E230-4529-969A-3A9949FE6CE1 Q37151378-8DFAB8C0-213B-44AD-8B4A-B107D97BC7FE Q37239234-A4EFE47B-DCEA-4F71-BD01-4E1D3D700F7F Q37633698-28644F68-9383-45DD-B6EE-112EF9B21A91 Q37673144-A846CC70-8F25-4D48-90CD-7E7970910E6F Q37727837-3A1A1601-7E6A-404E-8A0C-C44692AAD676 Q37747266-EC34FD84-6FF1-4406-9FC7-46F72383F936 Q38120042-100B57FA-C665-4D35-820A-92C3F150E455 Q38153910-7311D696-7041-47EC-80C8-3FC3B766831B Q38371073-0CDC8690-9888-426D-85CF-1F0C73BC025C Q38789402-B07ED1D3-9C74-4A4B-8436-7B4A753D9A6F Q38904514-F0016DDA-2B76-4A35-B6B7-9B6BB10A4405 Q38909857-54A2CA5B-B372-434D-94F1-F7F575558246 Q38998422-1B6F610A-618D-433D-B9B4-89B9C1BD0554 Q40065084-99C5DFD2-2B7A-4AF7-8711-59826CC46D44 Q40265879-0BC809FA-295D-4FC6-A763-15E59D2968D0 Q40438700-8F6EB39F-78B5-4D0A-A6E6-B425DE1E6E32 Q40687846-6EC2D804-699C-4D0D-9893-9FB48B40C056 Q45323705-7260DD5E-AE0C-4E86-BECD-8C103E0B0DB8 Q45324172-5061C6CD-5061-4913-B8D0-2188C50FC5E5 Q45961719-A357005F-7792-40FF-BB58-5CCBFBA23784 Q47104352-8A54E3FD-F9B6-474A-BD91-981DE9F6B83B Q47192141-D989C82D-1013-4344-B1BC-405A5531E134 Q47241799-C58FC8B1-07AA-4F2A-BF97-2AA22650E5A5 Q47552406-56F51778-8F53-4BAF-A2C0-55FC89B18FE8 Q57922233-29DB2AB2-E943-42CB-BD2E-0EC439EA9E87

P2860

AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis.

http://www.wikidata.org/entity/Q34244912

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

AMP-activated kinase restricts ...... hibiting fatty acid synthesis.

@ast

AMP-activated kinase restricts ...... hibiting fatty acid synthesis.

@en

AMP-activated kinase restricts ...... hibiting fatty acid synthesis.

@nl

type

label

AMP-activated kinase restricts ...... hibiting fatty acid synthesis.

@ast

AMP-activated kinase restricts ...... hibiting fatty acid synthesis.

@en

AMP-activated kinase restricts ...... hibiting fatty acid synthesis.

@nl

prefLabel

AMP-activated kinase restricts ...... hibiting fatty acid synthesis.

@ast

AMP-activated kinase restricts ...... hibiting fatty acid synthesis.

@en

AMP-activated kinase restricts ...... hibiting fatty acid synthesis.

@nl

P1433

Q34244912-26BFFDDB-F0CB-4D4C-BA4C-BAD8B0DAC0E0

P1476

Q34244912-2E2737A9-6CA7-4069-B3F5-8E7056C1713F

P2093

Q34244912-AC9E220C-5397-443E-ABD4-26C28839F4D8

Q34244912-CB08E996-2705-44AE-9743-140C0040A48E

P2860

Q34244912-01CD81A3-21C6-401F-B337-ED7515CCD239

Q34244912-029FB212-73EA-4018-B93B-A63248D6D100

Q34244912-03A6DB32-7C65-4F51-B0F8-C320506B86C9

Q34244912-05B35EBD-8058-4F3E-87BB-CF6CD33C5E18

Q34244912-05F1BEAF-FA81-4E2A-BF08-8D1E1C8A0176

Q34244912-085C66F0-7836-48B3-95F8-5DB1BE65E33D

Q34244912-0C2D05F0-C44A-459B-AC69-1F1F7D827C32

Q34244912-11C28456-7C90-48A3-8044-D42E6FFAB9A9

Q34244912-123D4BAD-2E2D-47E9-83A3-12DA62DBC13F

Q34244912-1343924D-F992-4008-B357-D58DCE43328E

P304

Q34244912-3BED426B-A235-4C8E-923D-40AD8283E79A

P31

Q34244912-D965BF94-61B1-4599-9689-92FBFA37F433

P356

Q34244912-C28A9E02-11C8-4F8C-A872-0BA253D58025

P433

Q34244912-6AB4EA38-1D89-4C2B-B066-7EE58BB57F7E

P478

Q34244912-8FB0AC56-4C8F-43B2-AA69-E7CDCAE9B017

P50

Q34244912-EB92B08B-10A3-4154-A708-EC721706073A

P577

Q34244912-BEDD735D-AE3C-4B5C-8AB5-AA8ABAD4334E

P5875

Q34244912-01585656-4699-43E9-8A02-3E1F007BD697

P698

Q34244912-10739540-A5FB-4383-BC40-F312DBE16533

P921

Q34244912-DD9A1641-82B3-4171-A09E-E4409FA76793

Q34244912-F45DACB0-C0D4-405E-8225-A9382A260694

P932

Q34244912-799CB2AA-751D-4B66-B25F-ECFCC08049B4

P356

JOURNAL.PPAT.1002661

P1433

P1476

AMP-activated kinase restricts ...... hibiting fatty acid synthesis.

@en

P2093

Daniel Schieffer

http://www.w3.org/2001/XMLSchema#string

Theresa S Moser

http://www.w3.org/2001/XMLSchema#string

P2860

Role of AMP-activated protein kinase in mechanism of metformin action

Structure of mammalian AMPK and its regulation by ADP

Innate immune recognition of viral infection

Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex

Autophagy in immunity and inflammation

CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

A kinome RNAi screen identified AMPK as promoting poxvirus entry through the control of actin dynamics

Intracellular distribution of rubella virus nonstructural protein P150

Flock house virus RNA replicates on outer mitochondrial membranes in Drosophila cells.

P304

e1002661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1002661

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224834028

http://www.w3.org/2001/XMLSchema#string

P698

22532801

http://www.w3.org/2001/XMLSchema#string

P921

Rift Valley fever phlebovirus

P932

3330235

http://www.w3.org/2001/XMLSchema#string